|Bid||18.98 x 2200|
|Ask||18.99 x 3200|
|Day's Range||18.81 - 19.11|
|52 Week Range||16.52 - 24.74|
|PE Ratio (TTM)||6.68|
|Earnings Date||Sep 25, 2018|
|Forward Dividend & Yield||0.64 (3.54%)|
|1y Target Est||17.82|
Zacks.com featured highlights include: Verso, Bed Bath, American Airlines, Avis Budget and Dillard's
Tariffs may not weigh on stocks as much as investors think next week, CNBC's Jim Cramer says. The "Mad Money" host shares his game plan for the week, which will include an interview with J.P. Morgan CEO Jamie Dimon. The reason for the record highs in the S&P 500 and Dow Jones Industrial Average is staring investors in the face, CNBC's Jim Cramer said on Friday.
Jim Cramer shares his game plan for the week ahead and explains why tariffs may not weigh on stocks as much as investors think.
Investors need to pay close attention to Bed Bath & Beyond (BBBY) stock based on the movements in the options market lately.
Given their thorough understanding of the stock market, it is prudent to pay heed to broker advice while designing a winning portfolio.
Of the 22 analysts that follow Bed Bath & Beyond (BBBY), 4.5% are favoring a “buy” as of September 20, while 59.1% are favoring a “hold,” and the remaining 36.4% are favoring a “sell” recommendation. On the same day, analysts had set an average price target of $17.82, which represents a potential decline of 6.1% from its current stock price of $18.98.
Analysts expect Bed Bath & Beyond (BBBY) to post EPS (earnings per share) of $0.50 in the fiscal second quarter, which represents a fall of 35.1% from $0.77 in the corresponding quarter of 2017. The decline in BBBY’s net margins is expected to offset the positive effects of revenue growth and share repurchases, resulting in lower EPS in the fiscal second quarter. Analysts expect BBBY’s net margins to fall from 3.7% in the second quarter of 2017 to 2.3%.
Analysts expect Bed Bath & Beyond (BBBY) to post revenue of $2.96 billion in the second quarter of 2018, which represents growth of 0.7% from $2.94 billion in the second quarter of 2017. The addition of new stores could drive the company’s revenue growth.
Bed Bath & Beyond (BBBY) is all set to release its fiscal second-quarter earnings after the market closes on September 26. As of September 19, Bed Bath & Beyond was trading at $18.98. The stock has fallen 5.9% since it released its fiscal first-quarter earnings on June 27.
Bed Bath & Beyond's (BBBY) dismal margins trend is concerning. Nevertheless, its solid strategies and transformation efforts are likely to boost quarterly results.
Bed Bath & Beyond (BBBY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, NY / ACCESSWIRE / September 18, 2018 / U.S. equities retreated from records Monday as President Donald Trump plans to announce an additional $200 billion in tariffs on Chinese products. The Dow ...
Raymond James raises its rating to market perform from underperform for Bed Bath & Beyond shares, predicting the retailer will report sales above expectations in its fiscal second quarter. "Our rating upgrade simply underscores our view that sales results for F2Q18 now seem more likely to reflect a better consumer sales environment than previously expected,” analyst Budd Bugatch says. Raymond James is getting more optimistic on Bed Bath & Beyond BBBY shares due to the improving economy.
Like many of its retail peers, Bed Bath & Beyond Inc. (NASDAQ: BBBY ) could post a big beat in second-quarter sales, but that won't necessarily read through to better near-term margins, according to Raymond ...
Shares of Bed Bath and Beyond Inc. rallied 1.7% in premarket trade Monday, after the home furnishings retailer was upgraded at Raymond James ahead of fiscal second-quarter results, citing expectations of better-than-expected same-store sales results. Analyst Budd Bugatch raised his rating to market perform, after being at underperform for the the past five months. The company is scheduled to report earnings on Sept. 26. Bugatch said while the company continues to face compressing margins, his upgrade "simply underscores our view that sales results for F2Q18 now seem more likely to reflect a better consumer sales environment than previously expected, thereby mirroring the results for overall retail and other retailers have posted during late spring and summer." With the stock underperforming the retail sector this year, Bugatch believes upbeat results will provided a "trading opportunity," leaving a bearish rating now "too harsh." The stock had tumbled 10.5% over the past three months, while the SPDR S&P Retail ETF has gained 4.9% and the S&P 500 has tacked on 4.5%.
Moody's Investors Service, ("Moody's") has affirmed the ratings on nine classes in JPMBB Commercial Mortgage Securities Trust 2015-C33.: Cl. A-1, Affirmed Aaa (sf); previously on Sep 15, 2017 ...
NEW YORK, NY / ACCESSWIRE / September 14, 2018 / GNC Holdings shares catapulted yesterday after traders learned that the company received the go-ahead to get a large investment from Harbin Pharmaceutical Group Holdings for $300 million. GNC Holdings, Inc. shares were up 26.30% at the close on Thursday with around 15.1 million shares traded. The Committee on Foreign Investment in the United States approved Harbin Pharmaceutical Group Holding's $300 million investment in GNC.
Bed Bath & Beyond shares are down 6% Thursday and have shed 75% of their value over the past five years as a business turnaround seems increasingly difficult.
The week on Wall Street brought some interesting quarterly results, along with some notable IPOs, acquisitions, and investigations.
The stock prices of both Home Depot (HD) and Lowe’s Companies (LOW) tend to move in tandem with analysts’ ratings. When analysts raise their price targets, the stock price of a company tends to move up and vice versa.